Weiye Li MD, PhD
Professor Emeritus of Ophthalmology, Drexel University College of Medicine, Philadelphia, Pennsylvania; Physician, Drexel Eye Physicians, Philadelphia, PennsylvaniaDr. Weiye Li is an Emeritus Professor of Ophthalmology at Drexel University College of Medicine. He served as the Director of both Ophthalmic Research and Retina Services at Drexel.
Dr. Weiye Li received his medical degree from the Second Medical College of Beijing, China, and received his doctorate from the University of Pennsylvania in Philadelphia. He completed a fellowship in retina vitreous diseases at Crozer-Chester Medical Center, Upland, Pennsylvania. Dr. Li was previously Chairman of the Department of Ophthalmology at Peking Union Medical College Hospital, one of the most competitive and internationally respected medical colleges in the People's Republic of China.
Dr. Li’s basic and clinical research focuses on diabetic retinopathy and age-related macular degeneration He is widely published in the field of ophthalmology and has earned many honors and awards for his research. He is also active in many organizations, including the Association of Research in Vision and Ophthalmology.
Recent Contributions to PracticeUpdate:
- Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy
- Utilizing Cystatin C for the Detection of Sight-Threatening Diabetic Retinopathy
- Macular Buckling vs Vitrectomy on Macular Hole–Associated Macular Detachment in Eyes With High Myopia
- Reticular Pseudodrusen and the Risk of Progression in Intermediate AMD
- Incidence and Risk Factors for Macular Atrophy in Acquired Vitelliform Lesions
- Associations Between Peripapillary RNFL and Choroidal Thickness With the Development and Progression of Diabetic Retinopathy
- Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration
- Brolucizumab for Diabetic Macular Edema
- Visual Outcomes Associated With Patterns of Macular Edema Resolution in CRVO Treated With Anti-VEGF Therapy
- Retinal Fluid and Visual Acuity During Intravitreal Aflibercept Treatment in Wet AMD